Pharma is just not wired to act in the public interest when the chips are down

It has been an interesting 24 hours for some of our goliaths of research funding. Starting with the positive, Cancer Research UK (CRUK) rolled out its new research strategy this morning: 'Beating Cancer Sooner.' Its bold new vision is to see 75% of people surviving the disease in the next twenty years. That's compared to the 50% … Continue reading Pharma is just not wired to act in the public interest when the chips are down

Pfizer undaunted by social media hurdles in clinical trial recruitment

This was reported last week in the US press but I have not seen it covered here in the UK. Pfizer has reeled-in its social media strategy for recruiting patients to a US clinical trial of over-active bladder drug, Detrol.  But it hopes to come back next year with a renewed 'virtual trial strategy.' In the meantime … Continue reading Pfizer undaunted by social media hurdles in clinical trial recruitment

Science and the budget, peer review and a spot of crowd-sourcing

Tomorrow is Budget day.  Having just finished AMRC's own budget and business plan for 2011-2012 all I can say is: George you know where I am if you want to crunch some last minute numbers? The Financial Times is reporting today that the Chancellor of the Exchequer will announce a £100million cash injection for capital … Continue reading Science and the budget, peer review and a spot of crowd-sourcing

UKCMRI Task Gets Bigger

So the UKCMRI partners were in front of the House of Commons Science and Technology Committee yesterday as were representatives of the local community.  Meanwhile the Science Minister, David Willetts, announced that the Government had agreed the business plan for the new centre as put forward by the Medical Research Council (MRC).   A good day all … Continue reading UKCMRI Task Gets Bigger